APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 42 filers reported holding APREA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $91,309 | -54.8% | 275,860 | -11.6% | 0.00% | – |
| Q3 2022 | $202,000 | -23.5% | 312,016 | -11.3% | 0.00% | – |
| Q2 2022 | $264,000 | -42.5% | 351,836 | +42.5% | 0.00% | – |
| Q1 2022 | $459,000 | -51.0% | 246,944 | -24.3% | 0.00% | – |
| Q4 2021 | $936,000 | -1.0% | 326,210 | +76.4% | 0.00% | – |
| Q3 2021 | $945,000 | -81.0% | 184,964 | -81.9% | 0.00% | -100.0% |
| Q2 2021 | $4,975,000 | -2.3% | 1,019,776 | +2.2% | 0.00% | 0.0% |
| Q1 2021 | $5,090,000 | +118.7% | 998,127 | +111.0% | 0.00% | – |
| Q4 2020 | $2,327,000 | +42.8% | 473,021 | +597.9% | 0.00% | – |
| Q3 2020 | $1,630,000 | -40.5% | 67,774 | -4.1% | 0.00% | -100.0% |
| Q2 2020 | $2,740,000 | +16017.6% | 70,660 | +14032.0% | 0.00% | – |
| Q1 2020 | $17,000 | -97.2% | 500 | -96.3% | 0.00% | – |
| Q4 2019 | $615,000 | – | 13,398 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Princeton Global Asset Management LLC | 100 | $444 | 0.00% |
| Quent Capital, LLC | 3 | $13 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |